Insights

Innovative Antibiotic Programs Prokaryotics has exclusive rights to develop and commercialize early-stage antibiotics targeting both Gram-negative and Gram-positive bacteria, presenting opportunities to integrate antimicrobial solutions into existing infectious disease portfolios.

Strategic Collaborations Recent partnerships with Basilea Pharmaceutica for broad-spectrum antifungals highlight the company's focus on innovative and collaborative R&D efforts, providing avenues for joint ventures or licensing opportunities across infectious disease treatments.

Growing Market Presence With recent news coverage and industry collaborations, Prokaryotics is gaining visibility in the biotech space, which can be leveraged to identify strategic partners, investors, or healthcare providers interested in antimicrobial innovations.

Focused Financial Opportunity Limited revenue range and relatively modest funding levels suggest potential for strategic investment, sales partnerships, or licensing deals to accelerate product development and market entry in the competitive antimicrobial sector.

Equipment and Tech Stack Use of cloud-based and web development technologies indicates a modern operational infrastructure, offering potential for digital health solutions or integrated research tools tailored to pharmaceutical development clients.

Prokaryotics, Inc. Tech Stack

Prokaryotics, Inc. uses 8 technology products and services including Cloudflare CDN, oEmbed, Backbone.js, and more. Explore Prokaryotics, Inc.'s tech stack below.

Cloudflare CDN

Content Delivery Network

oEmbed

Dev Tools

Backbone.js

Javascript Frameworks

Underscore.js

Javascript Libraries

jQuery Migrate

Javascript Libraries

Ninja Forms

Web Platform Extensions

GoDaddy Primer

Web Platform Extensions

Nginx

Web Servers

Prokaryotics, Inc. Email Formats	Example	Percentage
FLast@prokaryotics.com	JDoe@prokaryotics.com	50%
FLast@prokaryotics.com	JDoe@prokaryotics.com	50%

Prokaryotics, Inc. Email Formats

Example

Percentage

FLast@prokaryotics.com

JDoe@prokaryotics.com

50%

FLast@prokaryotics.com

JDoe@prokaryotics.com

50%

Frequently Asked Questions

Where is Prokaryotics, Inc.'s headquarters located?

Prokaryotics, Inc.'s main headquarters is located at 1000 Morris Avenue Stem Bldg. Suite 5-13 Union City, New Jersey 07083 United States. The company has employees across 2 continents, including North AmericaAsia.

What is Prokaryotics, Inc.'s official website and social media links?

Prokaryotics, Inc.'s official website is prokaryotics.com and has social profiles on LinkedIn Crunchbase.

What is Prokaryotics, Inc.'s NAICS code?

Prokaryotics, Inc.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Prokaryotics, Inc. have currently?

As of February 2026, Prokaryotics, Inc. has approximately 8 employees across 2 continents, including North AmericaAsia. Key team members include Ceo: P. D.President: H. A. S.Founder And Cso: T. R.. Explore Prokaryotics, Inc.'s employee directory with LeadIQ.

What industry does Prokaryotics, Inc. belong to?

Prokaryotics, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Prokaryotics, Inc. use?

Prokaryotics, Inc.'s tech stack includes Cloudflare CDNoEmbedBackbone.jsUnderscore.jsjQuery MigrateNinja FormsGoDaddy PrimerNginx.

What is Prokaryotics, Inc.'s email format?

Prokaryotics, Inc.'s email format typically follows the pattern of FLast@prokaryotics.com. Find more Prokaryotics, Inc. email formats with LeadIQ.

How much funding has Prokaryotics, Inc. raised to date?

As of February 2026, Prokaryotics, Inc. has raised $2.5M in funding. The last funding round occurred on Mar 08, 2018 for $2.5M.

When was Prokaryotics, Inc. founded?

Prokaryotics, Inc. was founded in 2017.

Prokaryotics, Inc.

Q: What is Prokaryotics, Inc.'s official website and social media links?

Prokaryotics, Inc.'s official website is prokaryotics.com. Prokaryotics, Inc. has social profiles on LinkedIn.

Q: How many employees does Prokaryotics, Inc. have currently?

Prokaryotics, Inc. has approximately 8 employees.

Q: What technology does Prokaryotics, Inc. use?

Prokaryotics, Inc.'s tech stack includes Microsoft 365, MySQL, Google Fonts API, X-Content-Type-Options, Priority Hints.

Pharmaceutical ManufacturingNew Jersey, United States2-10 Employees

Prokaryotics is a start-up biotechnology company resulting from licensing several novel antibiotic programs from Merck & Co., Inc. – by a team of former senior scientists at the company including the head of the Antimicrobial Early Discovery Unit, to optimize a number of Merck’s early-stage programs.  Prokaryotics has negotiated worldwide rights to develop, manufacture and commercialize pre-clinical assets and programs targeting both Gram-negative and Gram-positive bacteria.

Prokaryotics is an authentic antibacterial discovery organization committed to bringing forth innovative therapeutics to address the problem of multidrug resistant bacteria and combating the emerging global crisis of antibiotic resistance.

Insights

Similar companies to Prokaryotics, Inc.

QIAGEN

Bio-Rad Laboratories

New England Biolabs

Roche

Danaher Corporation

Thermo Fisher Scientific

Agilent Technologies

Illumina